Envisagenics Raises Series A Financing to Scale Its AI-powered RNA Splicing Drug Discovery Platform portfolioDynamk CapitalSeptember 29, 2021
Vectron Biosolutions to Boost Protein Production Offering with Acquisition of Secretion Platform from T3S Technologies and $2.7M Series A Financing Round Dynamk CapitalJune 17, 2021
Lightspeed Microscopy, Inc. raises $4M in Series A Financing Round with Plans to Revolutionize Pathology portfolioDynamk CapitalJune 15, 2021
Dynamk Capital Announces Final Closing of its Life Science Industrials Fund Dynamk CapitalApril 27, 2021
Curi Bio Raises $6M Series A Financing Round for iPSC-derived Predictive Platforms portfolioDynamk CapitalMarch 18, 2021
Lucid Scientific Secures $3 Million in Series Seed Financing Led by Dynamk Capital Dynamk CapitalOctober 1, 2020
Dynamk featured in Pharma’s Almanac article on disruptive Organ-on-a-Chip Dynamk CapitalOctober 1, 2020
Dynamk Launches Industry Insights Newsletter: Quarterly Trends, Transactions & Headlines Dynamk CapitalJuly 13, 2020
CellFE Closes $4.8M Seed Round Funding Co-led by Dynamk Capital and Cota Capital portfolioDynamk CapitalMarch 31, 2020
Pharma's Almanac Article: Facilitating the Commercialization of Disruptive Industrial Life Science Technologies Daniella KranjacMarch 19, 2020
CellFE Raises $3.6 Million in Series Seed Round Co-Led by Dynamk Capital and Cota Capital portfolioDynamk CapitalJanuary 16, 2020
Dynamk Capital participates in Life Science Investor Panel during JPMorgan Healthcare Week Daniella KranjacJanuary 10, 2020
RoosterBio Raises $15 Million in Series B Round Led by Dynamk Capital portfolioDynamk CapitalAugust 6, 2019
